TRANQUIS Trademark

Trademark Overview

On Monday, March 11, 2019, a trademark application was filed for TRANQUIS with the United States Patent and Trademark Office. The USPTO has given the TRANQUIS trademark a serial number of 88335115. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 2, 2023. This trademark is owned by Tranquis Therapeutics, Inc.. The TRANQUIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of brain-related diseases and nervous system disorders; pharmaceutical preparations acting on the brain and central nervous system; therapeutic pharmaceuticals and medicines for the treatment of brain-related diseases and nervous system disorders; therapeutic medicated preparations for the treatment of neurological diseases and nervous system disorders; pharmaceutical preparations for the treatment and prevention of inflammatory diseases; therapeutic medicated preparations for the treatment and prevention of inflammatory diseases
tranquis

General Information

Serial Number88335115
Word MarkTRANQUIS
Filing DateMonday, March 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of brain-related diseases and nervous system disorders; pharmaceutical preparations acting on the brain and central nervous system; therapeutic pharmaceuticals and medicines for the treatment of brain-related diseases and nervous system disorders; therapeutic medicated preparations for the treatment of neurological diseases and nervous system disorders; pharmaceutical preparations for the treatment and prevention of inflammatory diseases; therapeutic medicated preparations for the treatment and prevention of inflammatory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTranquis Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
Party NameTranquis Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Tuesday, January 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 2, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, May 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 12, 2022SOU EXTENSION 5 GRANTED
Tuesday, May 10, 2022SOU EXTENSION 5 FILED
Tuesday, May 10, 2022SOU TEAS EXTENSION RECEIVED
Saturday, December 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 3, 2021SOU EXTENSION 4 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 4 FILED
Friday, December 3, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 3, 2021SOU EXTENSION 3 GRANTED
Monday, May 3, 2021SOU EXTENSION 3 FILED
Monday, May 3, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 14, 2020SOU EXTENSION 2 GRANTED
Monday, September 14, 2020SOU EXTENSION 2 FILED
Monday, September 14, 2020SOU TEAS EXTENSION RECEIVED
Friday, March 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 25, 2020SOU EXTENSION 1 GRANTED
Wednesday, March 25, 2020SOU EXTENSION 1 FILED
Wednesday, March 25, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 29, 2019ASSIGNED TO LIE
Thursday, August 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 15, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, August 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 15, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, August 15, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2019NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2019NON-FINAL ACTION WRITTEN
Monday, May 20, 2019ASSIGNED TO EXAMINER
Friday, March 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 14, 2019NEW APPLICATION ENTERED

Related Keywords

tranquis treatment preparations diseases nervous system therapeutic pharmaceutical disorders prevention brain